Private Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Private Advisory Group's LLY Position: Q2 2026 in Review
Private Advisory Group increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $2.1M and bringing the position to 17,932 shares worth $21.5M. The position accounts for 1.16% of the portfolio, ranked #21.
Private Advisory Group first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. The position peaked at $29.1M in Q1 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Private Advisory Group held 17,932 shares of Eli Lilly worth $21.5M as of Q2 2026.
- Private Advisory Group bought 2,056 Eli Lilly shares in Q2 2026, an estimated $2.1M.
- Eli Lilly made up 1.16% of Private Advisory Group's portfolio in Q2 2026, its #21 holding.
- Private Advisory Group first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
- Private Advisory Group's Eli Lilly position peaked at $29.1M in Q1 2025.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Private Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.